Moscow, ID, United States of America

Keith D Miller

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tria Bioscience Corp.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith D Miller. Retrieved from https://idiyas.com/inventor/keith-d-miller-ar6fz3oa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keith D Miller: Innovator in Vaccine Delivery Systems

Introduction

Keith D Miller is a notable inventor based in Moscow, ID (US). He has made significant contributions to the field of vaccine delivery systems through his innovative research and development.

Latest Patents

Miller holds a patent for "Synthetic hapten carrier compositions and methods." This patent involves peptide monomers that comprise an amphipathic α-helical peptide, and optionally, at least one T cell epitope peptide. The invention also includes dimers and trimers made from these peptide monomers. These peptide conjugates are designed to be linked to a hapten, which is connected to a lysine or aspartic acid residue of the peptide monomer. The resulting peptide conjugates serve as effective vaccine delivery vehicles. He has 1 patent to his name.

Career Highlights

Miller is associated with Tria Bioscience Corp., where he continues to advance his research in the field of immunology and vaccine development. His work focuses on creating innovative solutions that enhance the efficacy of vaccines.

Collaborations

One of his notable coworkers is Christopher H Clegg, with whom he collaborates on various projects related to vaccine technology.

Conclusion

Keith D Miller's contributions to vaccine delivery systems highlight his role as an innovator in the field. His patent for synthetic hapten carrier compositions showcases his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…